Development of DNA drugs gives hope to lupus patients

A generation of DNA-like compounds, class R inhibitory oligonucleotides (INH-ODNs), have been shown to effectively inhibit cells responsible for the chronic autoimmune condition lupus. Researchers writing in BioMed Central's open access journal Arthritis Research and Therapy have demonstrated the anti-inflammatory effects of the INH-ODNs in both in vitro and mouse experiments...

Read the whole article on

More from